| 2024-05-15 | Sale | Blueprint Medicines Corporation BPMC | CHIEF FINANCIAL OFFICER | 3,850 0.0062% | $106.95 | $411,772 | -1.7% | |
| 2024-05-02 | Sale | Blueprint Medicines Corporation BPMC | CHIEF FINANCIAL OFFICER | 10,000 0.016% | $105.00 | $1.05M | -1.38% | |
| 2024-03-28 | Sale | Blueprint Medicines Corporation BPMC | CHIEF FINANCIAL OFFICER | 5,000 0.0082% | $95.00 | $475,000 | +9.12% | |
| 2024-03-15 | Sale | Blueprint Medicines Corporation BPMC | CHIEF FINANCIAL OFFICER | 13,734 0.0218% | $87.78 | $1.21M | +13.09% | |
| 2024-03-07 | Sale | Blueprint Medicines Corporation BPMC | CHIEF FINANCIAL OFFICER | 5,003 0.0081% | $90.69 | $453,722 | +4.75% | |
| 2023-03-06 | Sale | Blueprint Medicines Corporation BPMC | 3,007 0.0053% | $45.68 | $137,361 | +32.68% | ||
| 2022-03-03 | Sale | Blueprint Medicines Corporation BPMC | CHIEF FINANCIAL OFFICER | 1,328 0.0023% | $60.27 | $80,039 | -8.24% | |
| 2021-03-04 | Sale | Blueprint Medicines Corporation BPMC | Chief Financial Officer | 1,507 0.0024% | $86.76 | $130,749 | +2.9% | |
| 2020-03-09 | Sale | Blueprint Medicines Corporation BPMC | Chief Financial Officer | 800 0.0014% | $51.97 | $41,576 | +44.05% |